NervGen Pharma (9UA.F) Q3 2025 Earnings

27AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.08
-0.07
-0.05
-0.04

Details

Expected EPS
-0.04729482224999999
Actual EPS
-0.0819776919
Surprise EPS
-0.03
Surprise Percent
+73.33%

Description

NervGen Pharma (9UA.F) has reported earnings of -0.0819776919 per share for Q3 2025.

0 Comments

Share your thoughts